CurveBeam AI

Name: CurveBeam AI
Brand: CurveBeam AI

Cone Beam CT Imaging for Orthopedics and Bone Health AI Research

Est 2009|34 Ref Customers

LinkedIn 5K|Web traffic 3K|FTEs 61|HQ Hatfield, Pennsylvania, US

Published Oct 5, 2026

01Common complaints

- When a simpler modality is sufficient - If the majority of cases can be managed with standard weight-bearing radiographs and do not require 3D detail. - When interoperability is a hard requirement - If the workflow requires a single universal DICOM viewer across vendors/modalities and procurement cannot accept a CurveBeam-specific viewer. - When enterprise security evidence is mandatory upfront - If procurement requires publicly documented SOC 2 Type II / ISO 27001, SSO/SAML, SCIM, audit logs, and data residency commitments for cloud services. - When throughput is the top KPI and staffing is tight - If adding a new scan workflow that may slow daily operations is unacceptable and the organization cannot allocate dedicated staff/time for training and protocol optimization (community feedback suggests WBCT exams can slow daily throughput in some settings). - When broad whole-body CT capability is needed - If imaging needs extend beyond extremities/lower extremity alignment and require comprehensive MDCT protocols, a radiology department MDCT may be the better fit. - Current limitations acknowledged by the vendor - CubeVue dataset limitation - CubeVue is not a universal DICOM viewer and displays CurveBeam AI datasets only. - Soft tissue limitations (from vendor educational resources) - Vendor resources note reconstruction filters are tuned for hard tissue/bone edges and that soft tissue windowing is limited. - Features on the roadmap / not yet available - Autometrics and other AI-driven tools - The Cloud page indicates some tools are investigational and not available for sale in certain jurisdictions, implying a roadmap rather than general availability. - OssView status - OssView is described by vendor materials as investigational and not cleared/approved by the FDA for sale in the United States. - Scale limitations - Cloud storage/sharing scale, concurrency, and enterprise governance controls are not detailed publicly. - Security or compliance gaps - No public SOC 2 / ISO 27001; limited public detail on cloud security controls. - API limitations or integration constraints - No public API documentation was found; DICOM interoperability is referenced, but integration details are not enumerated.

Deal disqualifiers (poor fit)

Requirement for a universal DICOM viewer (CubeVue is not universal)
Procurement that requires publicly documented SOC 2 / ISO 27001 and SSO/SCIM before purchase
Low scan volume / very tight capital constraints
Sites with staffing resistance to adding CT-like workflows without additional compensation or credentialing clarity

02Why they buy

- unique selling points supported by vendor materials (presented in neutral terms) - Emphasis on WBCT for orthopedics - Vendor materials highlight imaging in natural stance for alignment and biomechanics assessment. - Point-of-care availability - Vendor materials emphasize a small footprint, operation on standard power, and claims of limited shielding requirements. - Ecosystem: viewer + cloud - CubeVue provides visualization and measurement tools for CurveBeam datasets. - CurveBeam AI Cloud is described by the vendor as providing HIPAA-aligned DICOM storage/transport for sharing and browser-based review. - Differentiation vs competitors (where evidence is limited) - Claims of AI-driven segmentation and measurement tools are described in vendor materials (for example, Autometrics and other AI features), but some AI capabilities are described as investigational and not available for sale in certain jurisdictions; independent validation of day-to-day clinical impact is limited in public sources. - Areas where competitors clearly have advantages - Competitors with broader enterprise reach may have more third-party reviews and more published enterprise security documentation.

03Field reports

- Availability of mainstream review-platform coverage - Gartner Peer Insights - No accessible product-specific Peer Insights review page for CurveBeam AI/CubeVue was found via public search; Peer Insights may require login and can be difficult to access programmatically. - G2 - G2 seller page exists for CurveBeam AI but shows limited or no reviews, indicating insufficient review volume for standard G2 insights. - TrustRadius - No readily accessible TrustRadius product page or reviews were found for CurveBeam AI (this is a niche medical imaging product not commonly covered on general B2B SaaS review platforms). - Vendor-published testimonials (positive, but not independent) - The CurveBeam AI website includes physician quotes describing clinical utility and workflow speed (for example, vendor content claims the combination of modalities can be completed in a very short duration). These are vendor-provided testimonials and should be weighted accordingly. - Community/social: Reddit (more candid; includes negative experiences) - Radiology technologist discussion (negative) - In r/Radiology, a user reported that using a CurveBeam CT machine for standing feet/ankles was burdensome and suggested it slowed department throughput. The user also raised a concern about employers requiring X-ray techs to perform CT tasks, and noted the system uses AI to assist image interpretation. - ASX_Bets thread with mixed sentiment - In r/ASX_Bets, a commenter claiming to be an X-ray tech reported negative experience using a CurveBeam machine for weight-bearing feet and ankles, while other participants discussed the company from an investor perspective. - What customers say they like (recurring themes across vendor + community) - Clinical/diagnostic value proposition - Weight-bearing CT under load is presented as enabling assessment of alignment and functional stance that conventional CT does not capture in a loaded position. - Point-of-care availability - Having 3D imaging available on-site rather than scheduling hospital CT is described as reducing patient delay in vendor materials and some user comments. - What customers complain about (recurring themes from community sources) - Workflow friction and throughput impact - Technologist reports suggest exam workflow can slow daily operations, implying positioning, scan steps, or post-processing may be time-consuming in real-world operations. - Scope-of-practice / staffing friction - Some technologist complaints frame the work as CT-level tasks being assigned to X-ray techs; regardless of legal scope, this reflects operational friction and training burden. - Why customers chose this product over alternatives (inferred) - Need for weight-bearing 3D imaging (clinical specialty differentiation) - Desire to keep imaging in-practice for faster access and potential revenue capture - Vendor claims of minimal shielding requirements, standard power needs, and a relatively small footprint - Why some customers left for competitors (churn reasons) - Not enough public evidence to quantify churn drivers. - Plausible churn drivers (inference) - Lower cost and simplicity of 2D radiography - Preference for hospital MDCT quality/workflow - Service/support or uptime concerns (not well evidenced publicly for CurveBeam AI specifically)

Vendor case studies / marketing content examples

CurveBeam AI publishes clinical application posts and resources (e.g., practice workflow webinars, literature summaries). These materials are useful for understanding claimed clinical utility but are vendor marketing and not independent ROI studies.

Scientific/clinical evidence (more independent than marketing, though not always directly about CurveBeam-branded devices)

Peer-reviewed articles in the WBCT and patient-specific instrumentation ecosystem discuss WBCT workflows and outcomes in total ankle arthroplasty (TAA) contexts. These articles are not necessarily CurveBeam AI customer case studies, but they support the general clinical rationale for WBCT.

Example: WBCT for patient-specific instrumentation in total ankle arthroplasty

Vendor materials summarize a study presented at a conference in 2021 reporting a high rate of neutral ankle alignment post-operatively when WBCT was used in PSI workflows; buyers should review the underlying study design, sample size, and reproducibility.

Critical evaluation of metrics and methodology

Vendor summary metrics should be validated by reviewing original study methods, sample sizes, and whether results replicate across independent sites.
Many WBCT studies focus on measurement accuracy and planning improvements rather than practice economics; independent ROI evidence is limited in public sources.

Mixed results / projects that struggled

Publicly accessible evidence of failed implementations is limited; however, technologist complaints and operational friction are noted anecdotally and can undermine time-to-value if not planned for.

04Best fit

Company sizes

Likely best fit
- Specialty clinics and orthopedic groups large enough to justify capital equipment and generate consistent scan volume (often multi-physician practices or groups with multiple locations)
- Hospitals adding orthopedic outpatient imaging capacity
Could be a stretch
- Very small practices without predictable scan volume or without staffing capacity to absorb new workflow complexity

Industries and verticals

Orthopedics
- Foot & ankle
- Hip/knee alignment and lower-extremity biomechanics
Podiatry
Sports medicine (adjacent)
Bone health research / investigational settings (some tools are investigational)

Roles and personas

Decision makers
- Orthopedic practice owners, administrators, CFO/finance
- Hospital imaging leadership / radiology administration
- Orthopedic service line directors
End users
- Radiologic technologists
- Orthopedic surgeons / podiatrists
- Radiologists (depending on interpretation model)

Pain points the product addresses

Need for 3D imaging under load to assess alignment and deformities
Reducing scheduling delays and patient friction from referrals to hospital CT
Supporting pre-op planning workflows and 3D measurement/visualization

Qualification criteria (great fit)

Clear clinical indications where WBCT changes decision-making
Adequate scan volume to justify fixed costs
Strong operational plan for technologist training and scheduling
Willingness to standardize around CurveBeam-specific datasets/viewer tooling

05The pitch

- What the product does (core value proposition in objective terms) - CurveBeam AI develops point-of-care cone beam CT (CBCT) imaging systems focused on extremity and weight-bearing CT (WBCT) for orthopedic and podiatry workflows, and provides companion software for visualization, measurement, and emerging AI-assisted analysis. - The portfolio includes on-site scanning hardware (e.g., foot/ankle through full lower-extremity) and software including a dedicated viewer (CubeVue) and a cloud-based sharing/processing platform (CurveBeam AI Cloud). - Target market and market positioning - Target buyers - Orthopedic practices and orthopedic group practices - Podiatry practices - Hospital outpatient imaging / orthopedic service lines - (Adjacent) sports medicine and foot/ankle specialty clinics - Positioning themes emphasized by the vendor - Emphasis on a small footprint, operation on standard power, and claims of minimal shielding requirements - Promoted differences for WBCT relative to conventional non-weight-bearing CT with respect to alignment and biomechanics under load - Vendor materials describe reduced scan times and availability for in-office use - Vendor references applicable extremity CT reimbursement codes and frames reimbursement in those terms - Company background (founding year, HQ, key leadership) - Corporate structure and origin - CurveBeam AI states it was formed in 2022 via a merger between CurveBeam, LLC and StraxCorp Pty Ltd. - HQ / offices - Operational HQ and global operations for product development, regulatory, manufacturing, and US sales/support: Hatfield, Pennsylvania, USA. - Corporate office for AI R&D and corporate functions: Melbourne, Victoria, Australia. - Founding year (important nuance) - Third-party sources and some event materials commonly cite CurveBeam’s origins around 2009 (as “CurveBeam was founded in 2009”). This likely reflects the pre-merger operating history rather than the 2022 “CurveBeam AI” corporate formation. - Funding and growth: investment rounds, acquisitions, estimated customer count/revenue if public - Public listing - The company is publicly listed on the Australian Securities Exchange; IPO materials and timeline are described on the company’s investor site. - Pre-IPO capital raise - The vendor announced a pre-IPO private placement in early 2023; public summaries note participating investors without detailed figures in product-facing materials. - IPO (investor-site summary) - Investor materials indicate the IPO process completed and the company was listed in 2023. - Operating/financial signals (non-audited secondary aggregators) - Secondary market-data aggregators show recent revenue and loss signals and indicate the company is loss-making; treat these figures as directional unless cross-checked against primary filings/annual reports. - Customer count / installed base - CurveBeam AI does not appear to publish a clear “number of installations/customers” figure on its main product pages; vendor materials include unquantified statements about usage across multiple regions but do not provide verified totals. - Pricing model with specific tiers and costs where available - Public pricing transparency is limited - The company does not publish list prices for hardware systems or subscription fees on the public website. - Software licensing signal - CubeVue download page indicates a license is required to activate 3D rendering and instructs users to contact the company to purchase a license. - Likely commercial structure (inference) - Based on typical medical imaging procurement patterns and the vendor’s sales motion, expect negotiated quotes for capital equipment (hardware), plus ongoing service/maintenance contracts and (for cloud/AI modules) recurring subscription fees. - Total cost of ownership considerations (implementation, training, hidden costs) - Potential TCO components buyers should model - Capital equipment purchase and site readiness (space, power, shielding; vendor asserts minimal shielding and standard power) - Ongoing service contracts (uptime, parts, preventative maintenance) - Software licenses (CubeVue 3D rendering license; cloud platform subscription) - IT integration costs - PACS/RIS integration and DICOM routing (where applicable) - Networking/security reviews if using cloud storage/sharing - Clinical workflow costs - Training for technologists on positioning protocols (WBCT positioning is often more operator-dependent than standard radiography) - Radiologist/orthopedist reading workflow (who interprets and documents findings) - Compliance/credentialing - Local/state requirements for who may operate CT-like equipment can impact staffing models (see complaints section: some technologists object to scope expectations) - Key competitors in the space (list 4-6 direct alternatives) - Planmed Verity (orthopedic CBCT) - Carestream OnSight 3D Extremity System - Xoran Technologies xCAT (point-of-care CBCT; often ENT-focused but relevant in CBCT POC imaging discussions) - Conventional multidetector CT (MDCT) in hospital radiology departments (workflow competitor; not “point-of-care”) - Standard weight-bearing radiography (2D) as the lower-cost alternative for many indications - Other extremity CBCT vendors exist, but CurveBeam AI and Planmed are frequently cited in WBCT contexts

Get a comprehensive analysis of CurveBeam AI including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →